Association of Preterm Birth With Prescription of Psychotropic Drugs in Adolescence and Young Adulthood.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Individuals born preterm have increased risk of mental health impairment compared with individuals born at term. The associations between preterm birth and attention-deficit/hyperactivity disorder and autism are well established; for depression, anxiety, psychotic and bipolar disorder, studies show divergent results. To compare the prescription of psychotropic drugs in adolescence and young adulthood between those born preterm and those born at term. This cohort study used registry data to identify all Norwegians born after 23 weeks of completed gestation between 1989 and 1998. Included individuals were those without registered birth defects, alive at age 10 years, and with available maternal data. Individuals were followed up from 2004 to 2016. Psychotropic drug prescriptions received from age 10 to 23 years were compared between preterm groups and peers born at term. Individuals were compared with their siblings to control for shared family confounding. Data analyses were performed from August 2018 through February 2020. Gestational age at birth (GA) was categorized in 4 groups: extremely preterm (GA, 23 weeks and 0 days to 27 weeks and 6 days), very preterm (GA, 28 weeks and 0 days to 31 weeks and 6 days), moderately or late preterm (GA, 32 weeks and 0 days to 36 weeks and 6 days), and full term (GA, 37 weeks and 0 days to 44 weeks and 6 days). Prescriptions of psychotropic drugs (ie, prescriptions specifically of psychostimulants, antidepressants, anxiolytics, hypnotics or sedatives, or antipsychotics or prescriptions of any of these 5 drugs) among preterm groups were compared with prescriptions among peers born at term and among siblings. Among 505 030 individuals (259 545 [51.4%] males; mean [SD] birth weight, 3533 [580] g), 762 individuals (0.2%) were extremely preterm, 2907 individuals (0.6%) were very preterm, 25 988 individuals (5.1%) were moderately or late preterm, and 475 373 individuals (94.1%) were full term. Individuals born preterm had increased risk of psychotropic drug prescription, with a dose-response association between GA and prescription. The extremely preterm group had higher rates of prescription for all drug types compared with peers born at term, with odds ratios from 1.7 (95% CI, 1.4-2.1) for antidepressants to 2.7 (95% CI, 2.1-3.4) for psychostimulants. The elevated odds of prescription of all types were less pronounced in the moderately to late preterm group, including odds ratios of 1.1 (95% CI, 1.0-1.1) for antidepressants and 1.2 (95% CI, 1.1-1.2) for psychostimulants. The increases in odds were smaller in the sibling comparison, and increases were not significant for several groups. For example, the OR for any prescription in the sibling analysis was 1.8 (95% CI, 1.2-2.8) in the very preterm group and 1.0 (95% CI, 0.9-1.1) in the moderately or late preterm group. This cohort study found higher rates of prescription of psychotropic drugs throughout adolescence and young adulthood among individuals with all degrees of preterm birth compared with those born at term. These results provide further evidence for an increased risk of mental health impairment among individuals born preterm and suggest that this is not restricted to the most preterm groups.
Identifiants
pubmed: 33710290
pii: 2777424
doi: 10.1001/jamanetworkopen.2021.1420
pmc: PMC7955275
doi:
Substances chimiques
Psychotropic Drugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e211420Références
Psychol Med. 2016 Jul;46(10):2227-38
pubmed: 27109930
J Pediatr. 2009 Feb;154(2):169-76
pubmed: 19081113
Br J Psychiatry. 2014 Nov;205(5):340-7
pubmed: 25368358
Pediatrics. 2017 Jul;140(1):
pubmed: 28759410
J Child Psychol Psychiatry. 2018 Jan;59(1):88-95
pubmed: 28748557
Lancet. 2008 Jan 19;371(9608):261-9
pubmed: 18207020
Pediatrics. 2009 Jan;123(1):e47-53
pubmed: 19117846
JAMA Pediatr. 2018 Aug 1;172(8):749-756
pubmed: 29946656
Curr Dir Psychol Sci. 2010 Oct;19(5):319-323
pubmed: 23645975
Pediatrics. 2016 Apr;137(4):
pubmed: 26944946
Pediatrics. 2011 May;127(5):858-65
pubmed: 21502231
Dev Med Child Neurol. 2007 Aug;49(8):597-602
pubmed: 17635205
Am J Epidemiol. 2010 Sep 1;172(5):537-9
pubmed: 20631043
N Engl J Med. 2008 Jul 17;359(3):262-73
pubmed: 18635431
BJOG. 2005 Feb;112(2):145-52
pubmed: 15663577
Pediatr Neurol. 2019 Jun;95:42-66
pubmed: 30975474
Lancet. 2012 Apr 28;379(9826):1630-40
pubmed: 22538178
PLoS One. 2015 Jun 26;10(6):e0130535
pubmed: 26114969
J Am Acad Child Adolesc Psychiatry. 2013 Apr;52(4):378-88
pubmed: 23582869
Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):742-751
pubmed: 28168780
Acta Paediatr. 2011 May;100(5):691-9
pubmed: 21244484
Int J Epidemiol. 2010 Dec;39(6):1522-30
pubmed: 20570995
Pediatrics. 2015 Mar;135(3):452-9
pubmed: 25667243
Dev Med Child Neurol. 2012 Nov;54(11):988-94
pubmed: 22924489
Pediatrics. 2014 Dec;134(6):1075-83
pubmed: 25367538
Semin Fetal Neonatal Med. 2012 Jun;17(3):163-9
pubmed: 22364677
Epidemiology. 2012 Sep;23(5):713-20
pubmed: 22781362
Arch Gen Psychiatry. 2012 Jun;69(6):E1-8
pubmed: 22660967
BJOG. 2000 Feb;107(2):228-37
pubmed: 10688507
Int J Epidemiol. 2011 Apr;40(2):345-9
pubmed: 21450688
Pediatrics. 2017 Apr;139(4):
pubmed: 28283612
Am J Public Health. 2013 Oct;103 Suppl 1:S46-55
pubmed: 23927516
JAMA Psychiatry. 2013 Nov;70(11):1231-40
pubmed: 24068297
Pediatrics. 2017 Feb;139(2):
pubmed: 28123043
Br J Obstet Gynaecol. 1998 Sep;105(9):933-6
pubmed: 9763041
Pediatrics. 2015 Sep;136(3):e599-608
pubmed: 26304830
Psychol Bull. 2017 Apr;143(4):347-383
pubmed: 28191983
Acta Paediatr. 1996 Jul;85(7):843-8
pubmed: 8819552
Acta Obstet Gynecol Scand. 2012 Mar;91(3):287-300
pubmed: 22085436